Impact of Behavioral Insomnia Treatments on Quality of Life in Post-menopausal Women
Tallent G, Cheng P, Fellman-Couture C, Tonnu C, Moss K, Arnedt T, and Drake C. Impact of behavioral insomnia treatments on quality of life in post-menopausal women. Sleep 2018; 41:A151.
Introduction: Insomnia in post-menopausal women is commonly associated with reduced quality of life. Preliminary data suggest that both Cognitive Behavioral Therapy for Insomnia (CBT-I) and the Sleep Restriction Therapy component of CBTI (SRT) reduce insomnia severity in this population. While SRT is the shorter alternative to full CBTI in improving insomnia (2 versus 6 weeks), the differences in impact on quality of life in this population have not yet been investigated. Methods: 148 females (mean age=56.5, SD=5.61) with insomnia concurrent with menopause were randomized to one of three conditions: CBT-I (N=50), SRT (N=49), and Information-only Control (IC, N=49). Quality of life was measured using the Short Form Health Survey (SF-36; range=0-100), administered at baseline, immediately post-treatment, and at 6-month follow-up. Results: Repeated-measures ANOVA revealed that the CBT-I, SRT, and IC did not differ at baseline on any domains (p>;.05) except for emotional role-limitations (p